A Study of the S-1 or Capecitabine as First-line Regimen in Patients with Metastatic Colorectal Cancer: A Real World Study

Objectives: To compare the 2-year overall survival (OS) rate and safety between patients using S-1 and capecitabine in the first-treatment of metastatic colorectal cancer in the real clinical setting. Methods: In this retrospective cohort study, patients satisfying the following criteria were identi...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yanan, Zheng, Tongsen, Zhang, Chunhui, Zhang, Yanqiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052859/
https://www.ncbi.nlm.nih.gov/pubmed/32194795
http://dx.doi.org/10.7150/jca.36929

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052859/
https://www.ncbi.nlm.nih.gov/pubmed/32194795
http://dx.doi.org/10.7150/jca.36929

Ejemplares similares